The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation
Open accessAbstract
The chemokine CXCL12 has been shown to regulate breast tumor growth, however, its mechanism in initiating distant metastasis is not well understood. Here, we generated a novel conditional allele of Cxcl12 in mice and used a fibroblast-specific Cre transgene along with various mammary tumor models to evaluate CXCL12 function in the breast cancer metastasis. Ablation of CXCL12 in stromal fibroblasts of mice significantly delayed the time to tumor onset and inhibited distant metastasis in different mouse models. Elucidation of mechanisms using in vitro and in vivo model systems revealed that CXCL12 enhances tumor cell intravasation by increasing vascular permeability and expansion of a leaky tumor vasculature. Furthermore, our studies revealed CXCL12 enhances permeability by recruiting endothelial precursor cells and decreasing endothelial tight junction and adherence junction proteins. High expression of stromal CXCL12 in large cohort of breast cancer patients was directly correlated to blood vessel density and inversely correlated to recurrence and overall patient survival. In addition, our analysis revealed that stromal CXCL12 levels in combination with number of CD31+ blood vessels confers poorer patient survival compared to individual protein level. However, no correlation was observed between epithelial CXCL12 and patient survival or blood vessel density. Our findings describe the novel interactions between fibroblasts-derived CXCL12 and endothelial cells in facilitating tumor cell intrvasation, leading to distant metastasis. Overall, our studies indicate that cross-talk between fibroblast-derived CXCL12 and endothelial cells could be used as novel biomarker and strategy for developing tumor microenvironment based therapies against aggressive and metastatic breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Various observations highlight activities of TGF-β on endothelial cells that may promote or repress angiogenesis, depending on the experimental setting264–266.”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [264]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997) · Science · doi:10.1126/science.275.5302.964 · Cited by 8,725
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,598
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 1×
“These secretomes can directly engage tumor cells, but can also reprogram other cell types in the TME, including macrophages, immune cells and endothelial cells to indirectly impact tumor cell invasion and metastasis [7].”
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Metastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2622 · Cited by 2,716
Takahashi, T., Kalka, C., Masuda, H., Chen, D., Silver, M., Kearney, M., Magner, M., Isner, J. M., & Asahara, T. (1999) · Nature Medicine · doi:10.1038/7434 · Cited by 2,421
Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S.-I., Kitamura, Y., Yoshida, N., Kikutani, H., & Kishimoto, T. (1996) · Nature · doi:10.1038/382635a0 · Cited by 2,382
Feig, C., Jones, J. O., Kraman, M., Wells, R. J. B., Deonarine, A., Chan, D. S., Connell, C. M., Roberts, E. W., Zhao, Q., Caballero, O. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320318110 · Cited by 2,100
Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., & Gasparini, G. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.24.1875 · Cited by 1,776
Cited by
Sorted by citations
CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
Farhood, B., Najafi, M., & Mortezaee, K. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27782 · Cited by 1,701
TGFβ biology in cancer progression and immunotherapy
Derynck, R., Turley, S. J., & Akhurst, R. J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0403-1 · Cited by 944
A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and Leukemia
Baryawno, N., Przybylski, D., Kowalczyk, M. S., Kfoury, Y. S., Sévère, N., Gustafsson, K. U., Kokkaliaris, K. D., Mercier, F., Tabaka, M., Hofree, M., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.040 · Cited by 916
Extracellular matrix (ECM) stiffness and degradation as cancer drivers
Najafi, M., Farhood, B., & Mortezaee, K. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27681 · Cited by 711
CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape
Rodríguez-García, A., Palazón, A., Noguera-Ortega, E., Powell, D. J., & Guedan, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01109 · Cited by 326
Cancer‐associated fibroblasts in breast cancer: Challenges and opportunities
Hu, D., Li, Z., Zheng, B., Lin, X., Pan, Y., Gong, P., Zhuo, W., Hu, Y., Chen, C., Chen, L., et al. (2022) · 癌症：英文版 · doi:10.1002/cac2.12291 · Cited by 310
CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications
Yang, Y., Li, J., Lei, W., Wang, H., Ni, Y., Liu, Y., Yan, H., Tian, Y., Wang, Z., Yang, Z. H., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.82317 · Cited by 267
Cancer associated fibroblasts in cancer development and therapy
Jia, H., Chen, X., Zhang, L., & Chen, M. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01688-0 · Cited by 262
Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment
Houthuijzen, J. M., & Jonkers, J. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9768-3 · Cited by 213
Contribution of regulatory T cells to cancer: A review
Najafi, M., Farhood, B., & Mortezaee, K. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27553 · Cited by 193
Tumor microenvironment: Interactions and therapy
Najafi, M., Goradel, N. H., Farhood, B., Salehi, E., Solhjoo, S., Toolee, H., Kharazinejad, E., & Mortezaee, K. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27425 · Cited by 185
MicroRNAs Contribute to Breast Cancer Invasiveness
Fridrichová, I., & Zmetakova, I. (2019) · Cells · doi:10.3390/cells8111361 · Cited by 159
Wang, K., Sukumar, U. K., Sadeghipour, N., Massoud, T. F., & Paulmurugan, R. (2021) · ACS Nano · doi:10.1021/acsnano.1c07587 · Cited by 119
Chu, D., Nguyen, T. T. P., Tien, N. L. B., Khoa, T. D., Nguyen, T.-T., Thanh, V. V., Quang, T. L., Bui, L. M., Pham, V.-H., Ngọc, V. T. N., et al. (2019) · Cells · doi:10.3390/cells8080857 · Cited by 124
Cancer‐associated fibroblasts: Secretions, interactions, and therapy
Farhood, B., Najafi, M., & Mortezaee, K. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27703 · Cited by 109
Houthuijzen, J. M., de Bruijn, R., van der Burg, E., Drenth, A. P., Wientjens, E., Filipovic, T., Bullock, E., Brambillasca, C. S., Pulver, E. M., Nieuwland, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-35793-w · Cited by 113
Han, Y., Jo, H., Cho, J., Dhanasekaran, D. N., & Song, Y. S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040925 · Cited by 104
Recent advances in understanding the complexities of metastasis
Chitty, J. L., Filipe, E. C., Lucas, M. C., Herrmann, D., Cox, T. R., & Timpson, P. (2018) · F1000Research · doi:10.12688/f1000research.15064.2 · Cited by 97
The Signaling Duo CXCL12 and CXCR4: Chemokine Fuel for Breast Cancer Tumorigenesis
Zielińska, K. A., & Katanaev, V. L. (2020) · Cancers · doi:10.3390/cancers12103071 · Cited by 85
Cao, Z., Quazi, S., Arora, S., Osellame, L. D., Burvenich, I. J. G., Janes, P. W., & Scott, A. M. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-024-01099-2 · Cited by 94
Mechanical signatures in cancer metastasis
Agrawal, A., Javanmardi, Y., Watson, S. A., Serwinski, B., Djordjevic, B., Li, W., Aref, A. R., Jenkins, R. W., & Moeendarbary, E. (2025) · npj Biological Physics and Mechanics. · doi:10.1038/s44341-024-00007-x · Cited by 89
Intravasation as a Key Step in Cancer Metastasis
Zavyalova, M. V., Denisov, E. V., Таширева, Л. А., Savelieva, O. E., Кайгородова, Е. В., Krakhmal, N. V., & Михайлович, П. В. (2019) · Biochemistry (Moscow) · doi:10.1134/s0006297919070071 · Cited by 86
Najafi, M., Ahmadi, A., & Mortezaee, K. (2019) · Cell Biology International · doi:10.1002/cbin.11187 · Cited by 80
Regulation of vascular permeability in cancer metastasis
Tomita, T., Kato, M., & Hiratsuka, S. (2021) · Cancer Science · doi:10.1111/cas.14942 · Cited by 77
Yang, P., Hu, Y., & Zhou, Q. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666191113113110 · Cited by 75
Xue, B., Chuang, C.-H., Prosser, H. M., Fuziwara, C. S., Chan, C., Sahasrabudhe, N. S., Kühn, M., Wu, Y., Chen, J., Biton, A., et al. (2021) · Genes & Development · doi:10.1101/gad.347344.120 · Cited by 74
Farhood, B., Najafi, M., Salehi, E., Goradel, N. H., Nashtaei, M. S., Khanlarkhani, N., & Mortezaee, K. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27594 · Cited by 72
Koenen, J., Bachelerie, F., Balabanian, K., Schlecht‐Louf, G., & Gallego, C. (2019) · Molecular Pharmacology · doi:10.1124/mol.118.115329 · Cited by 74
Lugo-Cintrón, K. M., Ayuso, J. M., White, B. R., Harari, P. M., Ponik, S. M., Beebe, D. J., Gong, M. M., & Virumbrales-Muñoz, M. (2020) · Lab on a Chip · doi:10.1039/d0lc00099j · Cited by 64
Liu, Y., Zhang, X., Gu, W., Su, H., Wang, X., Wang, X., Zhang, J., Xu, M., & Sheng, W. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.05.031 · Cited by 64
Self-citationCancer-Associated Fibroblasts in Breast Cancer Treatment Response and Metastasis
Fernández‐Nogueira, P., Fuster, G., Gutiérrez-Uzquiza, Á., Gascón, P., Carbó, N., & Bragado, P. (2021) · Cancers · doi:10.3390/cancers13133146 · Cited by 59
Mezawa, Y., Daigo, Y., Takano, A., Miyagi, Y., Yokose, T., Yamashita, T., Morimoto, C., Hino, O., & Orimo, A. (2019) · Cancer Medicine · doi:10.1002/cam4.2249 · Cited by 55
Cao, Y., Cao, W., Qiu, Y., Zhou, Y.-X., Guo, Q.-L., Gao, Y., & Lu, N. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104981 · Cited by 49
Kariri, Y. A., Aleskandarany, M. A., Joseph, C., Kurozumi, S., Mohammed, O. J., Toss, M. S., Green, A. R., & Rakha, E. A. (2020) · Pathobiology · doi:10.1159/000508337 · Cited by 52
Pradhan, R., Paul, S., Das, B., Sinha, S., Dash, S. R., Mandal, M., & Kundu, C. N. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109257 · Cited by 51
Zarychta, E., & Ruszkowska-Ciastek, B. (2022) · Biomedicines · doi:10.3390/biomedicines10020300 · Cited by 50
The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases
Hussain, S., Peng, B., Cherian, M. A., Song, J. W., Ahirwar, D. K., & Ganju, R. K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.598532 · Cited by 49
Self-citationGum polysaccharide/nanometal hybrid biocomposites in cancer diagnosis and therapy
Makvandi, P., Baghbantaraghdari, Z., Zhou, W., Zhang, Y., Manchanda, R., Agarwal, T., Wu, A., Maiti, T. K., Varma, R. S., & Smith, B. R. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107711 · Cited by 47
Tumor biology and multidisciplinary strategies of oligometastasis in gastrointestinal cancers
Zhao, Y., Li, J., Li, D., Wang, Z., Zhao, J., Wu, X., Sun, Q., Lin, P. P., Plum, P. S., Damanakis, A. I., et al. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.026 · Cited by 47
Li, Y., Li, F., Bai, X., Li, Y., Ni, C., Zhao, X., & Zhang, D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.658547 · Cited by 47
Wessels, D. J., Pradhan, N., Park, Y., Klepitsch, M. A., Lusche, D. F., Daniels, K. J., Conway, K. D., Voss, E. R., Hegde, S. V., Conway, T. P., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218854 · Cited by 43
Su, F., Daquinag, A. C., Ahn, S., Saha, A., Dai, Y., Zhao, Z., DiGiovanni, J., & Kolonin, M. G. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00160-9 · Cited by 43
Paolillo, M., Colombo, R., Serra, M., Belvisi, L., Papetti, A., Ciusani, E., Comincini, S., & Schinelli, S. (2019) · Cells · doi:10.3390/cells8111434 · Cited by 41
Zhang, W., Wang, J., Liu, C., Li, Y., Sun, C., Wu, J., & Wu, Q. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04714-2 · Cited by 42
Hsu, C., Chang, K.-P., Huang, Y., Liu, H., Hsueh, P., Gu, P., Yen, W., & Wu, C. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001654 · Cited by 40
The Tumor Vessel Targeting Strategy: A Double-Edged Sword in Tumor Metastasis
Li, X., Li, Y., Lu, W., Chen, M., Ye, W., & Zhang, D. (2019) · Cells · doi:10.3390/cells8121602 · Cited by 39
Engineered in vitro tumor models for cell-based immunotherapy
Ando, Y., Mariano, C. F., & Shen, K. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.076 · Cited by 38
The multifaceted roles of the chemokines CCL2 and CXCL12 in osteophilic metastatic cancers
Midavaine, É., Côté, J., & Sarret, P. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09974-2 · Cited by 39
Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma
Stafman, L. L., Williams, A. P., Garner, E. F., Aye, J. M., Stewart, J. E., Yoon, K. J., Whelan, K. F., & Beierle, E. A. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.10.008 · Cited by 36
Li, J., Luco, A.-L., Camirand, A., St‐Arnaud, R., & Kremer, R. B. (2021) · Endocrinology · doi:10.1210/endocr/bqab049 · Cited by 36
Wei, X., Tao, S., Mao, H., Zhu, H., Mao, L., Pei, W., Shi, X., Shi, Y., Zhang, S., Wu, Y., et al. (2023) · Gene · doi:10.1016/j.gene.2023.147230 · Cited by 35
Chang, C.-S., Seibel, A. J., Avendano, A., Cortes-Medina, M. G., & Song, J. W. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.201901399 · Cited by 34
Liu, C., Zhao, Q., & Yu, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.561595 · Cited by 31
Yi, X., Yan, Y., Li, L., Li, Q., Xiang, Y., & Huang, Y. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202010283 · Cited by 30
Cancer‐Associated Fibroblasts: Heterogeneity, Cancer Pathogenesis, and Therapeutic Targets
Li, Y., Liu, Q., Jing, X., Wang, Y., Jia, X., Yang, X., & Chen, K. (2025) · MedComm · doi:10.1002/mco2.70292 · Cited by 32
Feng, H., Cao, B., Peng, X., & Wei, Q. (2022) · BMC Cancer · doi:10.1186/s12885-022-09877-7 · Cited by 28
Beyond the barrier: the immune-inspired pathways of tumor extravasation
Russo, S. D., Liberati, F. R., Riva, A., Fonzo, F. D., Macone, A., Giardina, G., Arese, M., Rinaldo, S., Cutruzzolà, F., & Paone, A. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01429-1 · Cited by 29
The biological role of the CXCL12/CXCR4 axis in esophageal squamous cell carcinoma
Wu, X., Zhang, H., Sui, Z., Wang, Y., & Yu, Z. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0140 · Cited by 26
Arora, S., Khan, S. F., Zaki, A., Tabassum, G., Mohsin, M., Bhutto, H. N., Ahmad, T., Fatma, T., & Syed, M. A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.002 · Cited by 26
Targeting metastasis with nanomedicine
Pallares, R. M., Consolino, L., Wang, A., Lorenzi, F. D., Kiessling, F. M., Schroeder, A., & Lammers, T. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00358-7 · Cited by 28
Kaul, K., Benej, M., Mishra, S., Ahirwar, D. K., Yadav, M., Stanford, K. I., Jacob, N. K., Denko, N. C., & Ganju, R. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.753477 · Cited by 25
Self-citationInhibition of CXCR4 and CXCR7 Is Protective in Acute Peritoneal Inflammation
Ngamsri, K., Jans, C., Putri, R. A. M., Schindler, K., Gamper‐Tsigaras, J., Eggstein, C., Köhler, D., & Konrad, F. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00407 · Cited by 24
Chemokine signaling in cancer-stroma communications
Singh, A. J., & Gray, J. W. (2021) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-021-00621-7 · Cited by 23
The Role of Chemokines in Orchestrating the Immune Response to Pancreatic Ductal Adenocarcinoma
Lekan, A. A., & Weiner, L. M. (2024) · Cancers · doi:10.3390/cancers16030559 · Cited by 24
Garg, P., Jallepalli, V. R., & Verma, S. (2024) · Human Gene · doi:10.1016/j.humgen.2024.201272 · Cited by 22
Holter, J. C., Chang, C.-S., Avendano, A., Garg, A. A., Verma, A. K., Charan, M., Ahirwar, D. K., Ganju, R. K., & Song, J. W. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.888431 · Cited by 22
Self-citationRethinking the chemokine cascade in brain metastasis: Preventive and therapeutic implications
Maurya, S. K., Κhan, P., Rehman, A. U., Kanchan, R. K., Perumal, N., Mahapatra, S., Chand, H. S., Santamaria‐Barria, J. A., Batra, S. K., & Nasser, M. W. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.12.009 · Cited by 21
Self-citationSaha, T., & Lukong, K. E. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1513225 · Cited by 20
Rosado-Sanz, M., Martínez-Alarcón, N., Abellán-Soriano, A., Golfe, R., Trinidad, E. M., & de Mora, J. F. (2025) · Biomedicines · doi:10.3390/biomedicines13081945 · Cited by 20
Dong, Z., He, L., Wu, J., Xie, C., Geng, S., Wu, J., Zhong, C., & Li, X. (2025) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112473 · Cited by 19
Bone Marrow Niches and Tumour Cells: Lights and Shadows of a Mutual Relationship
Granata, V., Crisafulli, L., Nastasi, C., Ficara, F., & Sobacchi, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.884024 · Cited by 19
Deng, M., Odhiambo, W. O., Qin, M., To, T., Brewer, G. M., Kheshvadjian, A. R., Cheng, C. E., & Agak, G. W. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01725-4 · Cited by 18
Fibroblasts: The grey eminence of mammary gland development
Sumbal, J., Belisova, D., & Koledova, Z. S. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.10.012 · Cited by 22
Pharmacogenomic and epigenomic approaches to untangle the enigma of IL-10 blockade in oncology
Elemam, N. M., Mekky, R. Y., Rashid, G., Braoudaki, M., & Youness, R. A. (2024) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2023.26 · Cited by 19
Roles for growth factors and mutations in metastatic dissemination
Nataraj, N. B., Marrocco, I., & Yarden, Y. (2021) · Biochemical Society Transactions · doi:10.1042/bst20210048 · Cited by 17
Rajendiran, S., Smith‐Berdan, S., Kunz, L., Risolino, M., Selleri, L., Schroeder, T., & Forsberg, E. C. (2020) · Stem Cells · doi:10.1002/stem.3205 · Cited by 15
Chemokines in bone-metastatic breast cancer: Therapeutic opportunities
Wang, Y., Ren, S., Wang, Z., Wang, Z., Zhu, N., Cai, D., Ye, Z., & Ruan, J. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106815 · Cited by 15
Blocking c-MET/ERBB1 Axis Prevents Brain Metastasis in ERBB2+ Breast Cancer
Gautam, S. K., Kanchan, R. K., Siddiqui, J. A., Maurya, S. K., Rauth, S., Perumal, N., Atri, P., Venkata, R. C., Mallya, K. B., Mirza, S., et al. (2020) · Cancers · doi:10.3390/cancers12102838 · Cited by 15
Self-citationQusa, M. H., Abdelwahed, K. S., Siddique, A. B., & Sayed, K. A. E. (2021) · Nutrients · doi:10.3390/nu13051706 · Cited by 15
The Biophysics of Cancer: Emerging Insights from Micro‐ and Nanoscale Tools
Beshay, P. E., Cortes-Medina, M. G., Menyhert, M. M., & Song, J. W. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100056 · Cited by 16
Non-Coding RNAs in the Crosstalk between Breast Cancer Cells and Tumor-Associated Macrophages
Benedetti, A., Turco, C., Fontemaggi, G., & Fazi, F. (2022) · Non-Coding RNA · doi:10.3390/ncrna8010016 · Cited by 16
Li, Y., Tian, R., Liu, J., Li, J., Tan, H. L. E., Wu, Q., & Fu, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.940801 · Cited by 15
An emerging paradigm of CXCL16 involvement in cancer progression
Argyris, D. G., Anastasiadou, D. P., Filippou, P. S., & Karagiannis, G. S. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.05.006 · Cited by 13
D'Andrea, M. R., Cereda, V., Coppola, L., Giordano, G., Remo, A., & Santis, E. D. (2021) · Cancers · doi:10.3390/cancers13235917 · Cited by 14
Pu, Q., & Gao, H. (2023) · Cancers · doi:10.3390/cancers15225493 · Cited by 12
Schuler, L. A., & Murdoch, F. E. (2021) · Cancers · doi:10.3390/cancers13153725 · Cited by 13
Kui, L., Kong, Q., Yang, X., Pan, Y., Xu, Z., Wang, S., Chen, J., Wei, K., Zhou, X., Yang, X., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.684351 · Cited by 12
Effect of exercise on peritoneal microenvironment and progression of ovarian cancer.
Morrisson, M. J., Bi, F., Yang, K. B., Cady, S. L., Hartwich, T. M. P., Cerchia, A. P., Li, Z., Kim, J., Irwin, M. L., & Yang‐Hartwich, Y. (2021) · Europe PMC (PubMed Central) · Cited by 12
Breast Cancer Stem Cells Upregulate IRF6 in Stromal Fibroblasts to Induce Stromagenesis
Muralidharan, H., Hansen, T. V. O., Steinle, A., Schumacher, D., Stickeler, E., & Maurer, J. (2024) · Cells · doi:10.3390/cells13171466 · Cited by 10
Cell-mediated barriers in cancer immunosurveillance
Rezaie, J., Chodari, L., Mohammadpour-Asl, S., Jafari, A., & Niknam, Z. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122528 · Cited by 9
Glioblastoma drives protease-independent extracellular matrix invasion of microglia
Chang, C.-W., Bale, A. A., Bhargava, R., & Harley, B. A. C. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101475 · Cited by 9
Liu, M., Ye, W., Ji, Q., Zhang, B., Yang, Z., Liu, D., & Zhou, S. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02496-3 · Cited by 9
Li, J., Gu, X., Wan, G., Wang, Y., Chen, K., Chen, Q., & Lu, C. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04081-y · Cited by 9
Gong, W., Martin, T. A., Sanders, A. J., Jiang, A., Sun, P., & Jiang, W. G. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4811 · Cited by 9
Mechanism of DAPK1 for Regulating Cancer Stem Cells in Thyroid Cancer
You, M. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46070422 · Cited by 8
Liu, R., Su, L., Gao, S., Liu, W., & Wang, H. (2026) · Advanced Science · doi:10.1002/advs.202510043 · Cited by 9
Godina, C., Khazaei, S., Belting, M., Vallon‐Christersson, J., Nodin, B., Jirström, K., Isaksson, K., Bosch, A., & Jernström, H. (2024) · PLoS ONE · doi:10.1371/journal.pone.0305222 · Cited by 7
Lv, Y., Duan, T., Song, J., Liu, S., Zhou, Z., Ba, Y., Weng, S., Zuo, A., Xu, H., Luo, P., et al. (2026) · 癌症：英文版 · doi:10.34133/cancomm.0002 · Cited by 7
CXCL12 and CXCR4 as Potential Early Biomarkers for Luminal A and Luminal B Subtypes of Breast Cancer
Motyka, J., Gacuta, E., Kicman, A., Kulesza, M., Malinowski, P., & Ławicki, S. (2023) · Cancer Management and Research · doi:10.2147/cmar.s416382 · Cited by 7
The role of CXC chemokines and receptors in breast cancer
Masrour, M., Moeinafshar, A., Poopak, A., Razi, S., & Rezaei, N. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01662-7 · Cited by 8
Metadata
- Authors
- Ahirwar, D. K., Nasser, M. W., Ouseph, M. M., Elbaz, M., Cuitiño, M. C., Kladney, R. D., Varikuti, S., Kaul, K., Satoskar, A. R., Ramaswamy, B., Zhang, X., Ostrowski, M. C., Leone, G., & Ganju, R. K.
- Affiliations
- The Ohio State University (US)
- Corresponding author
- Leone, Gustavo
- Ganju, Ramesh K.
- ORCID
- Venue
- Oncogene
- Published
- 2018-05-03
- Volume
- 37
- Issue
- 32
- Pages
- 4428-4442
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- PMC
- PMC7063845
- OpenAlex
- W2800801906
- Cited by
- 162
- References
- 36
- Citations by year
- 2026: 15 · 2025: 17 · 2024: 35 · 2023: 12 · 2022: 13 · 2021: 23 · 2020: 18 · 2019: 17 · 2018: 12
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Defense
- Ohio State University
- Pelotonia
- National Cancer Institute (R01CA153490, R01CA109527, P01CA097189)
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- CXCL12, breast cancer metastasis, tumor cell intravasation, tumor stromal fibroblasts, vascular permeability, tumor vasculature, endothelial progenitor cells, endothelial tight junctions, blood vessel density, patient survival, tumor microenvironment, conditional alleles
- MeSH terms
- Animals, Breast Neoplasms, Cell Line, Cell Movement, Female, Fibroblasts, Mice, Transgenic, Neoplasm Invasiveness, Neoplasm Metastasis, Mammary Neoplasms, Animal, Endothelial Cells, Cell Line, Tumor, Mice, Chemokine CXCL12, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
